Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-10-05 Sale |
2021-10-05 5:33 pm |
XERIS PHARMACEUTICALS INC | XERS | JOHNSON KENNETH ERLAND See Remarks |
89,583 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-31 Tax Withholding |
2025-02-03 7:39 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON KENNETH ERLAND See Remarks |
41,318 | $3.56 | 320,446 (Direct) |
View |
| 2025-01-03 Tax Withholding |
2025-01-07 4:42 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON KENNETH ERLAND See Remarks |
12,401 | $3.61 | 361,764 (Direct) |
View |
| 2022-01-29 Tax Withholding |
2024-08-09 4:07 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON KENNETH ERLAND See Remarks |
9,804 | $2.11 | 373,036 (Direct) |
View |
| 2023-01-29 Tax Withholding |
2024-08-09 4:07 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON KENNETH ERLAND See Remarks |
11,029 | $1.26 | 373,036 (Direct) |
View |
| 2024-01-03 Tax Withholding |
2024-08-09 4:07 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON KENNETH ERLAND See Remarks |
12,400 | $2.24 | 373,036 (Direct) |
View |
| 2024-01-29 Tax Withholding |
2024-08-09 4:07 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON KENNETH ERLAND See Remarks |
10,747 | $2.66 | 373,036 (Direct) |
View |
| 2024-01-31 Tax Withholding |
2024-08-09 4:07 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON KENNETH ERLAND See Remarks |
15,131 | $2.46 | 373,036 (Direct) |
View |
| 2023-01-03 Tax Withholding |
2024-08-09 4:07 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON KENNETH ERLAND See Remarks |
12,400 | $1.12 | 373,036 (Direct) |
View |
| 2023-01-31 Tax Withholding |
2024-08-09 4:07 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON KENNETH ERLAND See Remarks |
3,393 | $1.24 | 373,036 (Direct) |
View |
| 2024-01-31 Option Award |
2024-01-31 5:04 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON KENNETH ERLAND See Remarks |
175,000 | $0 | 446,860 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-01 4:12 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON KENNETH ERLAND See Remarks |
100,000 | $0 | 269,783 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 6:17 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON KENNETH ERLAND See Remarks |
75,000 | $0 | 165,865 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-05 7:38 pm |
N/A 2027-02-04 |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON KENNETH ERLAND See Remarks |
322,083 | $0 | 322,083 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-01 4:12 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | JOHNSON KENNETH ERLAND See Remarks |
65,000 | $0 | 91,890 (Direct) |
View |
| 2020-08-14 Option Award |
2020-08-17 4:35 pm |
N/A 2030-08-14 |
XERIS PHARMACEUTICALS INC | XERS | JOHNSON KENNETH ERLAND See Remarks |
100,000 | $0 | 126,890 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-15 4:52 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | JOHNSON KENNETH ERLAND See Remarks |
775 | $2.26 | 26,890 (Direct) |
View |